A recipe for the next disaster: a new, pan-virus methodology for ramping up vaccine production
ZAPI have put in place a new pan-virus methodology for ramping up the production of new vaccines in the next crisis
Image by Mike Mareen via Shutterstock
One way of dealing with the threat of another pandemic like COVID-19 is investing in plug-and-play vaccine technologies that can respond to a wide variety of virus types. ZAPI created a new methodology for quickly designing and manufacturing a vaccine in the event of a new disease outbreak in humans or animals that consists of the assembly of only two components. The only variable is the immunogen, which will change depending on the target pathogen.
Dyadic International, Inc.: Dyadic to Present at ZAPI Stakeholders Virtual Meeting
JUPITER, FL / ACCESSWIRE / February 3, 2021 / Dyadic International, Inc. ( Dyadic ) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs, and improve the performance of vaccines, drugs and other biological products at flexible commercial scales, today announced that Ronen Tchelet, PhD, Dyadic s Chief Scientific Officer, will make a presentation during the European Union Innovative Medicines Initiative (IMI) Zoonotic Anticipation Preparedness Initiative - ZAPI Stakeholders Virtual Web Meeting to be held on February 4th and 5th, 2020. Dyadic s C1 gene expression platform has played an important role in the success of the ZAPI project , said Mark Emalfarb, Dyadic s CEO. Mr Emalfarb continued Our participation in the ZAPI project has led to several fully funded animal health
Dyadic to Present at ZAPI Stakeholders Virtual Meeting phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.